The Register · A provider

Keio University Hospital

Tokyo · Japan

Address & contact

https://www.hosp.keio.ac.jp/en/shinryo/international-patient-services/

Specialties

Kampo medicine international patient services psychedelic therapy research treatment-resistant depression cardiac diagnostics cardiac surgery clinical trials imaging radiology psychiatry cancer genomic testing whole exome sequencing Integrative medicine cancer care palliative care mindfulness-based meditation therapy complex skull base surgery cerebrovascular procedures brain tumors functional neurosurgery endoscopic techniques interventional neuroradiology ophthalmology cataract surgery refractive surgery plastic and reconstructive surgery general hospital services telemedicine obstetrics gynecology perinatal services second opinion services artificial insemination by donor

Reports that name this provider

Alternative Medicine Cost Savings in Japan: Established Division of International Patient Services in November 2023; operates Kampo Medicine Center through School of Medicine; partners with seven MEJ-accredited medical travel companies
Ayahuasca Treatment Legality in Japan: Conducting ongoing psilocybin clinical trial for treatment-resistant depression, described as the first clinical trial in Asia in the 21st century, led by Dr. Hiroyuki Uchida. Signed May 2025 joint research agreement with Otsuka Pharmaceutical focusing on regulatory compliance, clinical trial design, and professional training frameworks.
Cardiac Diagnostics in Japan: Established dedicated Division of International Patient Services in November 2023 to promote international outreach; offers coordination with medical travel partners supporting English, Chinese, Korean, Vietnamese, and Russian
Cardiac Surgery Quality in Japan: ranked #15 in Asia-Pacific for cardiac surgery (Newsweek 2025)
Clinical Trial Access in Japan: Listed as a major hospital facilitating clinical trial access for international patients with authorized medical coordinating agents.
Diagnostic Turnaround in Japan
ECT/TMS Availability in Japan: Maintains a Division of International Patient Services and accepts foreign patients across specialties including psychiatry
Genetic Testing Availability in Japan: Offers WES covering nearly all 20,000 human genes; self-funded cancer genomic tests range from several hundred thousand to nearly one million yen
Integrative Medicine Quality in Japan
Integrative Oncology Quality in Japan: Mindfulness-based meditation therapy formally evaluated at Keio University Hospital's Palliative Care Center with significant reductions in anxiety and depression
Neurosurgery Quality in Japan: Ranked #9 neurosurgical facility in Asia-Pacific (Newsweek 2025); offers WFNS-recognized international fellowship
Ophthalmologic Surgery Quality in Japan: Ranked #5 in Asia for cataract surgery. Ophthalmology department led by Professor Kazuno Negishi (since April 2021) who specialises in cataract and refractive surgery and ophthalmological optics.
Pathology Quality in Japan: Holds JCI accreditation. Operates Division of International Patient Services to coordinate care for overseas patients.
Post-Bariatric Body Surgery in Japan: Maintains plastic and reconstructive surgery department capable of complex procedures.
Post-Surgical Recovery Facilities in Japan: Implemented multilingual telemedicine platform for postoperative follow-up via secure video consultation
Prenatal Care Quality in Japan: Tertiary referral center equipped to manage full spectrum of high-risk pregnancy complications.
Second Opinion Services in Japan: Charges ¥22,000–¥44,000 depending on consultation length. Requires referral letter in Japanese or English. May not be able to provide opinions in languages other than Japanese.
Sperm Donation Availability in Japan: Conducted artificial insemination by donor (AID) services since 1948, was the dominant provider conducting approximately 1,500 procedures annually, suspended acceptance of new patients in August 2018 due to donor shortage.

← Back to all clinics